|
|
News Breaks | | | | January 23, 2013 | | 08:32 EDT |  | TSRX | Trius Therapeutics underwriters exercise option to buy 869,135 additional shares
Trius Therapeutics announced that the underwriters of its previously announced public offering of common stock that priced on January 17, have exercised their option to purchase an additional 869,135 shares of common stock. With the sale of the additional shares, Trius will have sold a total of 7,169,135 shares of common stock in the public offering at a price to the public of $4.75 per share, resulting in expected aggregate gross proceeds to Trius of approximately $34.1M, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Trius. | |
|
News For TSRX From The Last 14 Days Check below for free stories on TSRX the last two weeks. |
|
|
| May 13, 2013 | | 08:18 EDT | | TSRX | Trius Therapeutics annoucnes notice of patent applications
 Subscribe for More Information | |
|
|
|
|
|
|
